MQS Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-300
Closed -$276K 388
2026
Q1
$276K Buy
+300
New +$304K 0.19% 257
2024
Q2
Sell
-540
Closed -$420K 558
2024
Q1
$420K Sell
540
-173
-24% -$123K 0.24% 163
2023
Q4
$416K Buy
+713
New +$416K 0.23% 171
2023
Q2
Sell
-1,753
Closed -$602K 524
2023
Q1
$602K Sell
1,753
-608
-26% -$205K 0.39% 63
2022
Q4
$864K Buy
+2,361
New +$837K 0.59% 22

Other funds holding LLY

MQS Management's LLY Position: Q2 2026 in Review

MQS Management sold out of Eli Lilly (LLY) in Q2 2026, closing a stake of 300 shares — an estimated $276K sold.

MQS Management first reported a position in LLY in Q4 2022 and held it in 5 quarters. The position peaked at $864K in Q4 2022. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • MQS Management reported no remaining Eli Lilly position as of Q2 2026 after selling out during the quarter.
  • MQS Management sold 300 Eli Lilly shares in Q2 2026, an estimated $276K.
  • MQS Management first reported a position in Eli Lilly in Q4 2022 and held it in 5 quarters.
  • MQS Management's Eli Lilly position peaked at $864K in Q4 2022.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on MQS Management's 13F filing for Q2 2026, filed 7 Aug 2026.